Study shows ‘huge effect’ of PrEP on cutting HIV rates A world-first, Australian-led study has shown the medication’s significant impact on the widest scale yet – but gaps remain.
Can Australia be the first country to eliminate HIV transmission? Significant progress has been made, but experts say the country still has a long way to go to meet the 2022 target of virtual elimination.
Reducing uncertainty and increasing confidence in prescribing PrEP Expanding knowledge and attitudes of healthcare professionals prescribing PrEP is one of the keys to HIV prevention.
Research indicates success in varied methods of taking PrEP Following news of a man contracting HIV while on the preventive drug, newsGP talks to a sexual health physician about different approaches to taking the medication.
No longer a death sentence: Australia making progress in diagnosis and management of HIV Ahead of World AIDS Day, newsGP spoke with a sexual health expert about the progress in the fight against HIV.
Queensland targets HIV transmission with new funding The state has announced a new funding push aimed at helping at-risk people get access to the HIV-prevention therapy PrEP.
How close is Australia to becoming the first country to end HIV transmission? New prevention drugs, better testing and antiretroviral therapy have put us within reach of ending transmission of HIV in Australia. But challenges remain.
Rapid uptake of PrEP linked to declining condom use Experts have told newsGP the findings from a new study should not make GPs reluctant to prescribe the HIV-prevention medication.
Prescribing PrEP in general practice: What GPs need to know With the HIV-prevention drug PrEP now available on the PBS, GP and sexual health physician Dr Vincent Cornelisse talk to newsGP about how GPs and patients can increase their knowledge of what has been described as a ‘game-changing’ medication.
Australia a step closer to ending HIV transmission with PBS listing of prevention drug The HIV-prevention pill PrEP will now be more financially accessible to people at risk of HIV transmission after officially being added to the Pharmaceutical Benefits Scheme.